AzTrials
AzTrials

Suture MaterialsNCT03410433

Suture Materials: an Evaluation

A study testing Silk 4.0, PG 910 4.0 and PP 4.0 in people with Suture Materials, run by Universitaire Ziekenhuizen KU Leuven.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Many factors play a role when selecting an appropriate suture for optimal soft tissue healing in oral surgery. Moreover, the oral cavity has its specific challenges: it is an aqueous environment in which biofilm formation takes place on all surfaces. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Suture Materials
What is being tested?
Silk 4.0, PG 910 4.0 and PP 4.0
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
No sites listed yet
Study dates
Feb 2015to Nov 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • 36 patients
  • in need for periodontal surgery
  • patients in good general health
  • able to sign IC form

Who cannot join

  • patients that were deemed unlikely to comply with the study protocol, as judged by the examiner
  • patients who had a present alcohol and/or drug abuse

About this study

Official title: Split-mouth Analysis of Different Suture Materials in Periodontal Surgery: Microbiological and Clinical Aspects

Background: Many factors play a role when selecting an appropriate suture for optimal soft tissue healing in oral surgery. Moreover, the oral cavity has its specific challenges: it is an aqueous environment in which biofilm formation takes place on all surfaces. Therefore, oral surgery has specific demands for suture materials.

Aim: The primary objective of this study was to compare the bacterial load on different suture materials. The secondary objective was to determine the impact of suture material on decubitus.

Material \& methods: This prospective experimental study with a 'split-mouth' design enrolled 36 patients requiring oral surgery. Five different suture materials were compared regarding their microbiological load and decubitus at the suture removal. Bacterial accumulation on the same 5 suture materials was also tested in an in vitro biofilm model.

Being tested
Silk 4.0, PG 910 4.0, PP 4.0, Silk 5.0, PG910 5.0

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Silk 4.0Device

    Silk suture 4.0

  • PG 910 4.0Device

    PG 910 4.0

  • PP 4.0Device

    PP 4.0

  • Silk 5.0Device

    Silk 5.0

  • PG910 5.0Device

    PG910 5.0

  • PP 5.0Device

    PP 5.0

  • APG 5.0Device

    APG 5.0

  • ePTFE 5.0Device

    ePTFE 5.0

Study groups in NCT03410433
Study groupRoleWhat they receive
Silk 4.0Active comparatorSilk suture
Receives: Device: Silk 4.0
PG910 4.0Active comparatorVicryl Rapid suture
Receives: Device: PG 910 4.0
PP 4.0ExperimentalNon-absorbable polypropylene monofilament
Receives: Device: PP 4.0
Silk 5.0Active comparatorSilk suture
Receives: Device: Silk 5.0
PG910 5.0Active comparatorVicryl suture
Receives: Device: PG910 5.0
PP 5.0ExperimentalNon-absorbable polypropylene monofilament
Receives: Device: PP 5.0
APG 5.0ExperimentalAntibacterial Vicryl suture
Receives: Device: APG 5.0
ePTFE 5.0Experimentalexpanded polytetrafluoroethylene
Receives: Device: ePTFE 5.0

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accumulation of soft deposits

    Accumulation of soft deposits on each suture material was assessed visually as being present or absent before removing the knots.

    Measured: 7 to 14 days

Secondary outcomes (2)
  1. Area of inflammation

    Clinical photographs were taken, calibrated with a ruler of 0.5 mm accuracy as is illustrated in Figure 2, before and after suture removal in both parts of the clinical study. Subsequently, the area of inflammation surrounding the sutures was measured by two separate examiners using the image-analysis program, Image J® (NIH, Bethesda, Maryland, USA).

    Measured: 7 to 14 days

  2. Microbial deposits on the sutures

    The composition of the microbial deposits on the suture materials was examined with qPCR.

    Measured: 7 to 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2018
  2. Study startFeb 2015
  3. Primary completionNov 2016
  4. Study completionNov 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03410433
Sponsor's protocol ID
S58697
Status last verified
Jan 2018
First submitted
18 Jan 2018
Last updated
25 Jan 2018
Results posted
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Silk 4.0, PG 910 4.0 and PP 4.0 in people with Suture Materials, run by Universitaire Ziekenhuizen KU Leuven.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accumulation of soft deposits (time frame: 7 to 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in